Christopher Ritchlin
| Title | Professor |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Medicine |
|---|
| Address | University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 695
Rochester NY 14642
|
|---|
|
|
|
| 1981 |
|
| Alpha Omega Alpha | Albany Medical College | | 1982 |
|
| Stanley Poole Award for Excellence in Internal Medicine | Albany College | | 1991 |
|
| Henry Christian Award of Excellence in Clinical Research | American Federation of Clinical Research | | 1994 |
|
| Teacher of the Year Award | Rochester General Hospital | | 2003 |
-
| 2012 | Best Doctors in America | | 2004 |
|
| Irene Kohn Teaching Fellowship Award | Strong Memorial Hospital | | 2005 |
|
| Irene Kohn Teaching Award | Strong Memorial Hospital | | 2010 |
-
| 2012 | Marquis Who's Who |
-
Li J, Ju Y, Bouta EM, Xing L, Wood RW, Kuzin I, Bottaro A, Ritchlin CT, Schwarz EM. Efficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow. Arthritis Rheum. 2013 Jan; 65(1):130-8.
-
Ash Z, Ritchlin CT. GRAPPA Trainees Symposium 2011: A Report from the GRAPPA 2011 Annual Meeting. J Rheumatol. 2012 Nov; 39(11):2184-8.
-
Fitzgerald O, Ritchlin CT, Mease PJ. Biomarkers of Radiographic Progression in Psoriatic Arthritis: A Report from the GRAPPA 2011 Annual Meeting. J Rheumatol. 2012 Nov; 39(11):2189-92.
-
Rahimi H, Ritchlin CT. Altered bone biology in psoriatic arthritis. Curr Rheumatol Rep. 2012 Aug; 14(4):349-57.
-
Ritchlin C. Biomarker development in psoriatic arthritis. J Rheumatol Suppl. 2012 Jul; 89:57-60.
-
Ritchlin CT. Strategies for Biomarker Development in Psoriatic Disease: A Report from the GRAPPA 2010 Annual Meeting. J Rheumatol. 2012 Feb; 39(2):423-6.
-
Gladman DD, Ritchlin CT, Fitzgerald O. The Path Forward to Biomarker Discovery in Psoriatic Disease: A Report from the GRAPPA 2010 Annual Meeting. J Rheumatol. 2012 Feb; 39(2):434-6.
-
Ritchlin CT. GRAPPA Trainees Symposium 2010: A Report from the GRAPPA 2010 Annual Meeting. J Rheumatol. 2012 Feb; 39(2):394-7.
-
Hsu S, Papp KA, Lebwohl MG, Bagel J, Blauvelt A, Duffin KC, Crowley J, Eichenfield LF, Feldman SR, Fiorentino DF, Gelfand JM, Gottlieb AB, Jacobsen C, Kalb RE, Kavanaugh A, Korman NJ, Krueger GG, Michelon MA, Morison W, Ritchlin CT, Stein Gold L, Stone SP, Strober BE, Van Voorhees AS, Weiss SC, Wanat K, Bebo BF. Consensus guidelines for the management of plaque psoriasis. Arch Dermatol. 2012 Jan; 148(1):95-102.
-
Chiu YH, Mensah KA, Schwarz EM, Ju Y, Takahata M, Feng C, McMahon LA, Hicks DG, Panepento B, Keng PC, Ritchlin CT. Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP). J Bone Miner Res. 2012 Jan; 27(1):79-92.
-
Kobie JJ, Zheng B, Bryk P, Barnes M, Ritchlin CT, Tabechian DA, Anandarajah AP, Looney RJ, Thiele RG, Anolik JH, Coca A, Wei C, Rosenberg AF, Feng C, Treanor JJ, Lee FE, Sanz I. Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor. Arthritis Res Ther. 2011; 13(6):R209.
-
Bouta EM, Wood RW, Perry SW, Brown EB, Ritchlin CT, Xing L, Schwarz EM. Measuring intranodal pressure and lymph viscosity to elucidate mechanisms of arthritic flare and therapeutic outcomes. Ann N Y Acad Sci. 2011 Dec; 1240(1):47-52.
-
Taylor PC, Ritchlin C, Mendelsohn A, Baker D, Kim L, Xu Z, Mack M, Kremer J. Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumab. J Rheumatol. 2011 Dec; 38(12):2572-80.
-
Gossec L, Smolen JS, Gaujoux-Viala C, Ash Z, Marzo-Ortega H, van der Heijde D, Fitzgerald O, Aletaha D, Balint P, Boumpas D, Braun J, Breedveld FC, Burmester G, Cañete JD, de Wit M, Dagfinrud H, de Vlam K, Dougados M, Helliwell P, Kavanaugh A, Kvien TK, Landewé R, Luger T, Maccarone M, McGonagle D, McHugh N, McInnes IB, Ritchlin C, Sieper J, Tak PP, Valesini G, Vencovsky J, Winthrop KL, Zink A, Emery P. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis. 2012 Jan; 71(1):4-12.
-
Li J, Zhou Q, Wood RW, Kuzin I, Bottaro A, Ritchlin CT, Xing L, Schwarz EM. CD23+/CD21hi B-cell translocation and ipsilateral lymph node collapse is associated with asymmetric arthritic flare in TNF-Tg mice. Arthritis Res Ther. 2011; 13(4):R138.
-
Mease P, Genovese MC, Gladstein G, Kivitz AJ, Ritchlin C, Tak PP, Wollenhaupt J, Bahary O, Becker JC, Kelly S, Sigal L, Teng J, Gladman D. Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial. Arthritis Rheum. 2011 Apr; 63(4):939-48.
-
Coates LC, Ritchlin CT. GRAPPA Trainees Symposium 2009: a report from the GRAPPA 2009 annual meeting. J Rheumatol. 2011 Mar; 38(3):526-9.
-
Coates LC, Jonckheere CL, Molin S, Mease PJ, Ritchlin CT. Summary of the International Federation of Psoriasis Associations (IFPA) meeting: a report from the GRAPPA 2009 annual meeting. J Rheumatol. 2011 Mar; 38(3):530-9.
-
Anandarajah AP, El-Taha M, Peng C, Reed G, Greenberg JD, Ritchlin CT. Association between focal erosions and generalised bone loss in psoriatic arthritis. Ann Rheum Dis. 2011 Jul; 70(7):1345-7.
-
Kwok WE, You Z, Seo G, Lerner A, Totterman S, Ritchlin C, Monu J. High-resolution interleaved water-fat MR imaging of finger joints with chemical-shift elimination. J Magn Reson Imaging. 2011 Jan; 33(1):245-51.
-
Ritchlin CT. Therapeutic considerations in spondyloarthritis patients who fail tumour necrosis factor antagonists. Best Pract Res Clin Rheumatol. 2010 Oct; 24(5):683-92.
-
Reddy SM, Anandarajah AP, Fisher MC, Mease PJ, Greenberg JD, Kremer JM, Reed G, Chen R, Messing S, Kaukeinen K, Ritchlin CT. Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry. J Rheumatol. 2010 Dec; 37(12):2566-72.
-
Gladman DD, Mease PJ, Choy EH, Ritchlin CT, Perdok RJ, Sasso EH. Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT. Arthritis Res Ther. 2010; 12(3):R113.
-
Mensah KA, Mathian A, Ma L, Xing L, Ritchlin CT, Schwarz EM. Mediation of nonerosive arthritis in a mouse model of lupus by interferon-alpha-stimulated monocyte differentiation that is nonpermissive of osteoclastogenesis. Arthritis Rheum. 2010 Apr; 62(4):1127-37.
-
Kremer J, Ritchlin C, Mendelsohn A, Baker D, Kim L, Xu Z, Han J, Taylor P. Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2010 Apr; 62(4):917-28.
-
Mensah KA, Ritchlin CT, Schwarz EM. RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens. J Cell Physiol. 2010 Apr; 223(1):76-83.
-
Gladman DD, Landewé R, McHugh NJ, Fitzgerald O, Thaci D, Coates L, Mease PJ, Qureshi AA, Krueger GG, Ritchlin CT, Kavanaugh AF, Garg A. Composite measures in psoriatic arthritis: GRAPPA 2008. J Rheumatol. 2010 Feb; 37(2):453-61.
-
Coates LC, McGonagle DM, Hodgson R, Gisondi P, Kavanaugh AF, Qureshi AA, Fitzgerald O, Mease PJ, Garg A, Rosen CF, Ridley D, Gladman DD, Krueger GG, Ritchlin CT, Helliwell PS. Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008. J Rheumatol. 2010 Feb; 37(2):448-52.
-
Ritchlin CT, Qureshi AA, de Vlam K, Pitzalis C, Helliwell PS, Mease PJ, Gladman DD, Krueger GG, Kavanaugh AF, Fitzgerald O. Biomarkers in psoriasis and psoriatic arthritis: GRAPPA 2008. J Rheumatol. 2010 Feb; 37(2):462-7.
-
Chiu YG, Shao T, Feng C, Mensah KA, Thullen M, Schwarz EM, Ritchlin CT. CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Res Ther. 2010; 12(1):R14.
-
Anandarajah AP, Ory P, Salonen D, Feng C, Wong RL, Ritchlin CT. Effect of adalimumab on joint disease: features of patients with psoriatic arthritis detected by magnetic resonance imaging. Ann Rheum Dis. 2010 Jan; 69(1):206-9.
-
Schwarz EM, Proulx ST, Ritchlin CT, Boyce BF, Xing L. The role of bone marrow edema and lymphangiogenesis in inflammatory-erosive arthritis. Adv Exp Med Biol. 2010; 658:1-10.
-
Kwok WE, You Z, Monu J, Seo G, Ritchlin C. High-resolution uniform MR imaging of finger joints using a dedicated RF coil at 3T. J Magn Reson Imaging. 2010 Jan; 31(1):240-7.
-
Anandarajah AP, Ritchlin CT. The diagnosis and treatment of early psoriatic arthritis. Nat Rev Rheumatol. 2009 Nov; 5(11):634-41.
-
Guo R, Zhou Q, Proulx ST, Wood R, Ji RC, Ritchlin CT, Pytowski B, Zhu Z, Wang YJ, Schwarz EM, Xing L. Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis. Arthritis Rheum. 2009 Sep; 60(9):2666-76.
-
Ritchlin CT, Proulx S, Schwarz ES. Translational perspectives on psoriatic arthritis. J Rheumatol Suppl. 2009 Aug; 83:30-4.
-
Ritchlin C. The quest for a biomarker of circulating osteoclast precursors. Arthritis Res Ther. 2009; 11(3):113.
-
Wang JC, Kobie JJ, Zhang L, Cochran M, Mosmann TR, Ritchlin CT, Quataert SA. An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platform. J Immunol Methods. 2009 Feb 28; 341(1-2):106-16.
-
Mease PJ, Reich K. Alefacept with methotrexate for treatment of psoriatic arthritis: open-label extension of a randomized, double-blind, placebo-controlled study. J Am Acad Dermatol. 2009 Mar; 60(3):402-11.
-
Ritchlin CT, Kavanaugh A, Gladman DD, Mease PJ, Helliwell P, Boehncke WH, de Vlam K, Fiorentino D, Fitzgerald O, Gottlieb AB, McHugh NJ, Nash P, Qureshi AA, Soriano ER, Taylor WJ. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis. 2009 Sep; 68(9):1387-94.
-
Mease PJ, Ory P, Sharp JT, Ritchlin CT, Van den Bosch F, Wellborne F, Birbara C, Thomson GT, Perdok RJ, Medich J, Wong RL, Gladman DD. Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT). Ann Rheum Dis. 2009 May; 68(5):702-9.
-
Ritchlin CT. The comparative effectiveness of methotrexate and anti-tumor necrosis factor therapy in psoriatic arthritis. Curr Rheumatol Rep. 2008 Aug; 10(4):295-6.
-
Mensah KA, Schwarz EM, Ritchlin CT. Altered bone remodeling in psoriatic arthritis. Curr Rheumatol Rep. 2008 Aug; 10(4):311-7.
-
Ritchlin C, Tausk F. Centers for psoriasis: a comprehensive approach to patient care, education and research. Curr Opin Rheumatol. 2008 Jul; 20(4):381-3.
-
Coates LC, Anderson RR, Fitzgerald O, Gottlieb AB, Kelly SG, Lubrano E, McGonagle DG, Olivieri I, Ritchlin CT, Tan AL, De Vlam K, Helliwell PS. Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review. J Rheumatol. 2008 Jul; 35(7):1438-42.
-
Proulx ST, Kwok E, You Z, Papuga MO, Beck CA, Shealy DJ, Calvi LM, Ritchlin CT, Awad HA, Boyce BF, Xing L, Schwarz EM. Elucidating bone marrow edema and myelopoiesis in murine arthritis using contrast-enhanced magnetic resonance imaging. Arthritis Rheum. 2008 Jul; 58(7):2019-29.
-
Ritchlin CT. From skin to bone: translational perspectives on psoriatic disease. J Rheumatol. 2008 Jul; 35(7):1434-7.
-
Colbert RA, Deodhar AA, Khan MA, Lories RJ, Maksymowych WP, Reveille JD, Ritchlin CT, Rosenbaum JT, Targan SR, Weisman M, Clegg DO. 2007 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). J Rheumatol. 2008 Jul; 35(7):1398-402.
-
Proulx ST, Kwok E, You Z, Papuga MO, Beck CA, Shealy DJ, Ritchlin CT, Awad HA, Boyce BF, Xing L, Schwarz EM. Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography. Arthritis Rheum. 2007 Dec; 56(12):4024-37.
-
Ritchlin C. Psoriatic disease--from skin to bone. Nat Clin Pract Rheumatol. 2007 Dec; 3(12):698-706.
-
Lebwohl M, Bagel J, Gelfand JM, Gladman D, Gordon KB, Hsu S, Kalb RE, Kimball AB, Korman NJ, Krueger GG, Mease P, Morison WL, Paller A, Pariser DM, Ritchlin C, Strober B, Van Voorhees A, Weinstein GD, Young M, Horn L. From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis. J Am Acad Dermatol. 2008 Jan; 58(1):94-105.
-
Kavanaugh A, Ritchlin C, Boehncke WH. Quality indicators in psoriatic arthritis. Clin Exp Rheumatol. 2007 Nov-Dec; 25(6 Suppl 47):98-101.
-
Anandarajah AP, Schwarz EM, Totterman S, Monu J, Feng CY, Shao T, Haas-Smith SA, Ritchlin CT. The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis. Ann Rheum Dis. 2008 Mar; 67(3):296-301.
-
Proulx ST, Kwok E, You Z, Beck CA, Shealy DJ, Ritchlin CT, Boyce BF, Xing L, Schwarz EM. MRI and quantification of draining lymph node function in inflammatory arthritis. Ann N Y Acad Sci. 2007 Nov; 1117:106-23.
-
Gladman DD, Mease PJ, Healy P, Helliwell PS, Fitzgerald O, Cauli A, Lubrano E, Krueger GG, van der Heijde D, Veale DJ, Kavanaugh A, Nash P, Ritchlin C, Taylor W, Strand V. Outcome measures in psoriatic arthritis. J Rheumatol. 2007 May; 34(5):1159-66.
-
Gladman DD, Mease PJ, Strand V, Healy P, Helliwell PS, Fitzgerald O, Gottlieb AB, Krueger GG, Nash P, Ritchlin CT, Taylor W, Adebajo A, Braun J, Cauli A, Carneiro S, Choy E, Dijkmans B, Espinoza L, van der Heijde D, Husni E, Lubrano E, McGonagle D, Qureshi A, Soriano ER, Zochling J. Consensus on a core set of domains for psoriatic arthritis. J Rheumatol. 2007 May; 34(5):1167-70.
-
Keeling SO, Landewe R, van der Heijde D, Bathon J, Boers M, Garnero P, Geusens P, El-Gabalawy H, Inman RD, Kraus VB, Kvien TK, Mease PJ, Ostergaard M, Ritchlin C, Syversen SW, Maksymowych WP. Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive protein. J Rheumatol. 2007 Mar; 34(3):623-33.
-
Pariser DM, Bagel J, Gelfand JM, Korman NJ, Ritchlin CT, Strober BE, Van Voorhees AS, Young M, Rittenberg S, Lebwohl MG, Horn EJ. National Psoriasis Foundation clinical consensus on disease severity. Arch Dermatol. 2007 Feb; 143(2):239-42.
-
Gladman DD, Mease PJ, Ritchlin CT, Choy EH, Sharp JT, Ory PA, Perdok RJ, Sasso EH. Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial. Arthritis Rheum. 2007 Feb; 56(2):476-88.
-
Schwarz EM, Ritchlin CT. Clinical development of anti-RANKL therapy. Arthritis Res Ther. 2007; 9 Suppl 1:S7.
-
Ritchlin C, Tausk F. A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents. Ann Rheum Dis. 2006 Dec; 65(12):1541-4.
-
Mallbris L, Ritchlin CT, Ståhle M. Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep. 2006 Oct; 8(5):355-63.
-
Ritchlin C, Maksymowych W. Radiographic progression in ankylosing spondylitis patients treated with infliximab. Curr Rheumatol Rep. 2006 Aug; 8(4):253-4.
-
Ritchlin C, Maksymowych W. MRI outcomes in AS patients after two years of etanercept therapy. Curr Rheumatol Rep. 2006 Aug; 8(4):253-4.
-
Ritchlin C. Efficacy and safety of infliximab for the treatment of psoriatic arthritis. Nat Clin Pract Rheumatol. 2006 Jun; 2(6):300-1.
-
Kavanaugh AF, Ritchlin CT. Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines. J Rheumatol. 2006 Jul; 33(7):1417-21.
-
Ritchlin CT. Therapies for psoriatic enthesopathy. A systematic review. J Rheumatol. 2006 Jul; 33(7):1435-8.
-
Schwarz EM, Looney RJ, Drissi MH, O'Keefe RJ, Boyce BF, Xing L, Ritchlin CT. Autoimmunity and bone. Ann N Y Acad Sci. 2006 Apr; 1068:275-83.
-
Ritchlin C. Newer therapeutic approaches: spondyloarthritis and uveitis. Rheum Dis Clin North Am. 2006 Feb; 32(1):75-90, viii.
-
Gladman DD, Mease PJ, Krueger G, van der Heidje DM, Antoni C, Helliwell PS, Kavanaugh AF, Nash P, Ritchlin CT, Strand CV, Taylor W. Outcome measures in psoriatic arthritis. J Rheumatol. 2005 Nov; 32(11):2262-9.
-
Mease PJ, Gladman DD, Ritchlin CT, Ruderman EM, Steinfeld SD, Choy EH, Sharp JT, Ory PA, Perdok RJ, Weinberg MA. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2005 Oct; 52(10):3279-89.
-
Ritchlin CT. Pathogenesis of psoriatic arthritis. Curr Opin Rheumatol. 2005 Jul; 17(4):406-12.
-
Ritchlin CT. Doxycycline in undifferentiated spondyloarthropathy. Curr Rheumatol Rep. 2005 Jun; 7(3):171-2; discussion 172.
-
Ritchlin CT. Treatment of reactive arthritis with azithromycin. Curr Rheumatol Rep. 2005 Jun; 7(3):171.
-
Anandarajah A, Ritchlin CT. Treatment update on spondyloarthropathy. Curr Opin Rheumatol. 2005 May; 17(3):247-56.
-
Gladman DD, Ritchlin C, Helliwell PS. Psoriatic arthritis clinical registries and genomics. Ann Rheum Dis. 2005 Mar; 64 Suppl 2:ii103-5.
-
Veale DJ, Ritchlin C, FitzGerald O. Immunopathology of psoriasis and psoriatic arthritis. Ann Rheum Dis. 2005 Mar; 64 Suppl 2:ii26-9.
-
Batliwalla FM, Li W, Ritchlin CT, Xiao X, Brenner M, Laragione T, Shao T, Durham R, Kemshetti S, Schwarz E, Coe R, Kern M, Baechler EC, Behrens TW, Gregersen PK, Gulko PS. Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis. Mol Med. 2005 Jan-Dec; 11(1-12):21-9.
-
Anandarajah AP, Ritchlin CT. Treatment update on spondyloarthropathy. From NSAIDs and DMARDs to anti-TNF-alpha agents. Postgrad Med. 2004 Nov; 116(5):31-6, 39-40.
-
Ritchlin CT, Schwarz EM, O'Keefe RJ, Looney RJ. RANK, RANKL and OPG in inflammatory arthritis and periprosthetic osteolysis. J Musculoskelet Neuronal Interact. 2004 Sep; 4(3):276-84.
-
Ritchlin CT. Treatment of psoriasis with intramuscular alefacept. Curr Rheumatol Rep. 2004 Aug; 6(4):290-1.
-
Ritchlin CT. Etanercept monotherapy in psoriasis. Curr Rheumatol Rep. 2004 Aug; 6(4):290-1.
-
Ritchlin CT. Efalizumab therapy in plaque psoriasis. Curr Rheumatol Rep. 2004 Aug; 6(4):289-91.
-
Ritchlin CT. Comparison of methotrexate and cyclosporine therapy in psoriasis. Curr Rheumatol Rep. 2004 Aug; 6(4):289, 291.
-
Ritchlin CT. Mechanisms of erosion in rheumatoid arthritis. J Rheumatol. 2004 Jul; 31(7):1229-37.
-
Anandarajah AP, Ritchlin CT. Pathogenesis of psoriatic arthritis. Curr Opin Rheumatol. 2004 Jul; 16(4):338-43.
-
Mease PJ, Ritchlin CT, Martin RW, Gottlieb AB, Baumgartner SW, Burge DJ, Whitmore JB. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol. 2004 Jul; 31(7):1356-61.
-
Gladman DD, Helliwell P, Mease PJ, Nash P, Ritchlin C, Taylor W. Assessment of patients with psoriatic arthritis: a review of currently available measures. Arthritis Rheum. 2004 Jan; 50(1):24-35.
-
Li P, Schwarz EM, O'Keefe RJ, Ma L, Looney RJ, Ritchlin CT, Boyce BF, Xing L. Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Arthritis Rheum. 2004 Jan; 50(1):265-76.
-
Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM. Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest. 2003 Mar; 111(6):821-31.
-
Anandarajah AP, Ritchlin CT. Etanercept in psoriatic arthritis. Expert Opin Biol Ther. 2003 Feb; 3(1):169-77.
-
Ritchlin CT. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor-alpha. Curr Rheumatol Rep. 2002 Dec; 4(6):497.
-
Ritchlin CT. Intravenous pamidronate in treatment of non-steroidal anti-inflammatory drug-refractory ankylosing spondylitis. Curr Rheumatol Rep. 2002 Dec; 4(6):498-9.
-
Daikh BE, Kalmar JJ, Ritchlin CT. Pseudoxanthoma elasticum masquerading as Sjögren's syndrome. J Clin Rheumatol. 2002 Apr; 8(2):89-93.
-
Ritchlin CT, Daikh BE. Recent advances in the treatment of the seronegative spondyloarthropathies. Curr Rheumatol Rep. 2001 Oct; 3(5):399-403.
-
Zeltser R, Valle L, Tanck C, Holyst MM, Ritchlin C, Gaspari AA. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein. Arch Dermatol. 2001 Jul; 137(7):893-9.
-
Ritchlin C, Haas-Smith SA. Expression of interleukin 10 mRNA and protein by synovial fibroblastoid cells. J Rheumatol. 2001 Apr; 28(4):698-705.
-
Ritchlin C. Fibroblast biology. Effector signals released by the synovial fibroblast in arthritis. Arthritis Res. 2000; 2(5):356-60.
-
Ritchlin C, Haas-Smith SA, Hicks D, Cappuccio J, Osterland CK, Looney RJ. Patterns of cytokine production in psoriatic synovium. J Rheumatol. 1998 Aug; 25(8):1544-52.
-
Ritchlin C, Haas-Smith S. Collagenase and stromelysin expression in rheumatoid synovium and cartilage: comment on the article by Wolfe et al. Arthritis Rheum. 1994 Dec; 37(12):1831-3.
-
Zwillich SH, Ritchlin CT. Olsalazine in Reiter's syndrome. J Rheumatol. 1994 Nov; 21(11):2169-70.
-
Ritchlin C, Dwyer E, Bucala R, Winchester R. Sustained and distinctive patterns of gene activation in synovial fibroblasts and whole synovial tissue obtained from inflammatory synovitis. Scand J Immunol. 1994 Sep; 40(3):292-8.
-
Hogan M, Sherry B, Ritchlin C, Fabre M, Winchester R, Cerami A, Bucala R. Differential expression of the small inducible cytokines GRO alpha and GRO beta by synovial fibroblasts in chronic arthritis: possible role in growth regulation. Cytokine. 1994 Jan; 6(1):61-9.
-
Winchester R, Su F, Ritchlin C. Alteration of synoviocytes by inflammation--the source of a persistent non-immunologic drive in synovitis: analysis of levels of mRNA expression by a simple multi-gene assay. Clin Exp Rheumatol. 1993 Mar-Apr; 11 Suppl 8:S87-90.
-
Ritchlin CT, Chabot RJ, Alper K, Buyon J, Belmont HM, Roubey R, Abramson SB. Quantitative electroencephalography. A new approach to the diagnosis of cerebral dysfunction in systemic lupus erythematosus. Arthritis Rheum. 1992 Nov; 35(11):1330-42.
-
Sorsa T, Konttinen YT, Lindy O, Ritchlin C, Saari H, Suomalainen K, Eklund KK, Santavirta S. Collagenase in synovitis of rheumatoid arthritis. Semin Arthritis Rheum. 1992 Aug; 22(1):44-53.
-
Porges AJ, Beattie SL, Ritchlin C, Kimberly RP, Christian CL. Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia. J Rheumatol. 1992 Aug; 19(8):1191-4.
-
Konttinen YT, Lindy O, Suomalainen K, Ritchlin C, Saari H, Vauhkonen M, Lauhio A, Santavirta S, Sorsa T. Substrate specificity and activation mechanisms of collagenase from human rheumatoid synovium. Matrix. 1991 Dec; 11(6):395-403.
-
Bucala R, Ritchlin C, Winchester R, Cerami A. Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med. 1991 Mar 1; 173(3):569-74.
-
Ritchlin CT, Winchester RJ. Potential mechanisms for coordinate gene activation in the rheumatoid synoviocyte: implications and hypotheses. Springer Semin Immunopathol. 1989; 11(3):219-34.
|
Ritchlin's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
